Trial intelligence / Profile preview

Methotrexate Plus Letrozole Versus Methotrexate Alone in the Medical Management of Ectopic Pregnancy

IRCT20250921067316N1Phase 3Completed

Sponsor
Urmia University of Medical Sciences
Start
Nov 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of methotrexate and letrozole in Ectopic pregnancy (EP) (2 arms), sponsored by Urmia University of Medical Sciences. Started Nov 2025; status: completed.

02

Drugs

methotrexateletrozole
03

Conditions

Ectopic pregnancy (EP)

Beyond the preview

Go deeper on IRCT20250921067316N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250921067316N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call